Trial intelligence / Profile preview

Daflon added to conventional treatment for acute hemorrhoids

IRCT20141201020178N9Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Apr 2018
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of diosmin in hemorrhoid (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Anal pain score, Bleeding status and 1 more. Started Apr 2018; status: completed.

02

Drugs

diosmin
03

Conditions

hemorrhoid

Beyond the preview

Go deeper on IRCT20141201020178N9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141201020178N9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call